Synthesis of C60 derivatives for photoaffinity labeling

Tetrahedron Letters

Volumn 45, Issue 3, 2004, Pages 527-529

  Okada, Eiji ^a,b   Komazawa, Yuka ^a,b   Kurihara, Masaaki ^a   Inoue, Hideshi ^b   Miyata, Naoki ^a   Okuda, Haruhiro ^a   Tsuchiya, Toshie ^a   Yamakoshi, Yoko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; AZIRIDINE DERIVATIVE; DIMETHYLFULLEROPYRROLIDINE; FUNCTIONAL GROUP; PHENYL GROUP; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BINDING AFFINITY; MOLECULAR INTERACTION; PHOTOAFFINITY LABELING; PHOTOSENSITIVITY; SYNTHESIS;

EID: 0346363695     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.10.212     Document Type: Article

References (30)

1. Jensen A.W., Wilson S.R., Schuster D.I. Bioorg. Med. Chem. 4:1996;767-786.
2. Da Ros T., Prato M. Chem. Commun. 1999;663-669.
3. Wilson S.R. Kadish K.M., Ruoff R.S. Fullerenes: Chemistry, Physics and Technology. 2000;437-466 A John Wiley and Sons, New York.
4. Foote C.S. Prassodes K. Physics and Chemistry of the Fullerene. 1994;79-96 Kluwer Academic, Dordrecht.
5. Foote C.S. Top. Curr. Chem. 169:1994;347-363.
6. Guldi D.M., Prato M. Acc. Chem. Res. 33:2000;695-703.
7. Guldi D.M., Kamat P.V. Kadish K.M., Ruoff R.S. Fullerenes: Chemistry, Physics and Technology. 2000;225-282 A John Wiley and Sons, New York.
8. Krusic P.J., Wasserman E., Parkinson B.A., Malone B., Holler E.R. Jr., Keizer P.N., Morton J.R., Preston K.F. J. Am. Chem. Soc. 114:1991;6274-6275.
9. Arbogast J.W., Foote C.S., Kao M. J. Am. Chem. Soc. 114:1992;2277-2279.
10. Brezova V., Stasko A., Rapta P., Domschke G., Bartl A., Dunch L. J. Phys. Chem. 99:1995;16234-16241.
11. Yamakoshi Y., Sueyoshi S., Fukuhara K., Miyata N., Masumizu T., Kohno M. J. Am. Chem. Soc. 120:1998;12363-12364.
12. Chiang L., Lu F.-J., Lin J.-T. J. Chem. Soc., Chem. Commun. 1995;1283-1284.
13. Okuda K., Mashino T., Hirobe M. Bioorg. Med. Chem. Lett. 6:1994;539.
14. Friedman S.H., DeCamp D.L., Sijbesma R.P., Srdanov G., Wudl F., Kenyon G.L. J. Am. Chem. Soc. 115:1993;6506-6509.
15. Sijbesma R.P., Srdanov G., Wudl F., Castoro J.A., Wilkins C., Friedman S.H., DeCamp D.L., Kenyon G.L. J. Am. Chem. Soc. 115:1993;6510-6512.
16. Schinazi R.F., Sijbesma R.P., Srdanov G., Hill C.L., Wudl F. Antimicrob. Agents Chemother. 37:1993;1707-1710.
17. Toniolo C., Bianco A., Maggini M., Scorrano G., Prato M., Marastoni M., Tomatis R., Spisani S., Palu R., Blair D.E. J. Med. Chem. 37:1994;4558-4562.
18. Yamakoshi Y., Yagami T., Fukuhara K., Sueyoshi S., Miyara N. J. Chem. Soc., Chem. Commun. 1994;517-518.
19. Iwata N., Mukai T., Yamakoshi Y., Hara S., Yanase Y., Shoji M., Endo T., Miyata N. Fullerene Sci. Technol. 6:1998;213-226.
20. Miyata, N.; Yamakoshi, Y.; Inoue, H.; Kojima, M.; Takahashi, K.; Iwata, N. In Fullerenes: Recent Advances in the Chemistry and Physics of Fullerenes and Related Materials; Kadish, K. M., Ruoff, R. S., Eds.; The Electrochemical Society, Inc.: Pennington, NJ, 1998; Vol. 6, pp 1227-1235.
21. Fleming S.A. Tetrahedron. 46:1995;12479-12520.
22. Maggini M., Scorrano G., Prato M. J. Am. Chem. Soc. 115:1993;9798-9799.
23. Wilson S.R., Wang Y., Gao J., Tan X. Tetrahedron Lett. 37:1996;775-778.
24. Tan X., Schuster D.I., Wilson S.R. Tetrahedron Lett. 39:1998;4187-4190.
25. 60 (36 mg, 0.05 mmol) and D,L-alanine (9.2 mg, 0.10 mmol) in 1,2-dichlorobenzene (10 mL), acetaldehyde (11 mg, 0.25 mmol) was added and the mixture stirred at 120°C for 20 h. The reaction process was checked by HPLC [silica gel column, solvent: benzene-EtOAc (10:1)]. The reaction mixture was purified by silica gel column chromatography (hexane-benzene-EtOAc) to give brown solid 2 (9.0 mg, 0.011 mmol, y=22% ) as a cis- and trans-mixture.
26. 3N was added. The products (cis- and trans-isomers) were separated by silica gel column chromatography (hexane-benzene-EtOAc) to give cis-5 (8.9 mg, 9.5 μmol, y=38% ) and trans-5 (13.3 mg, 14.2 μmol, y=57% ).
27. 2) to give cis-9 (2.5 mg, 2.5 μmol, y=20% ) and trans-9 (5.6 mg, 5.6 μmol, y=44% ).
28. -), 720.
29. Kitahara A., Satoh K., Nishimura K., Ishikawa T., Ruike K., Tsuda H., Ito N. Cancer Res. 44:1984;2698-2703.
30. Satoh K., Hitahara A., Soma Y., Inaba Y., Hatayama I., Sato K. Proc. Natl. Acad. Sci. U.S.A. 82:1985;3964-3968.